No abstract available
MeSH terms
-
Anti-Allergic Agents / administration & dosage*
-
COVID-19 / complications
-
COVID-19 / diagnosis
-
COVID-19 / immunology*
-
COVID-19 / virology
-
Chronic Urticaria / drug therapy*
-
Chronic Urticaria / immunology
-
Female
-
Humans
-
Injections, Subcutaneous
-
Lung / diagnostic imaging
-
Middle Aged
-
Omalizumab / administration & dosage*
-
SARS-CoV-2 / immunology
-
SARS-CoV-2 / isolation & purification
-
Symptom Flare Up*
-
Time Factors
-
Tomography, X-Ray Computed
-
Treatment Outcome
Substances
-
Anti-Allergic Agents
-
Omalizumab